“On October 1, in the Republic of Belarus, the vaccination of volunteers will start within the holding of a double-blind random placebo-controlled study of Sputnik-V vaccine,” the message said.
100 Belarusians will participate in the clinical trial of the medicine developed by N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology. The clinical trials will take place at eight medical establishments chosen as the research centers. Two Belarusian clinics have already received the first batches of the Sputnik-V vaccine.
Belarus became the first country where the clinical trials of the Russian vaccine started.
On August 11, President of Russia Vladimir Putin reported that the first vaccine against coronavirus was registered in Russia.
The vaccine would be produced by N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology and the Russian Binnopharm Company. According to Murashko, finalizing takes place of the technical regulations for scaling of production at the number of Russian productions.
Earlier, the Health Ministry of Russia released to the civil circulation the first batch of Sputnik V vaccine against the coronavirus.